Abstract: The present invention relates to methods of treatment for treating or preventing injury to cardiovascular or heart tissue in a subject in need thereof by administering an effective amount of thymosin ?4 (T?4) peptide.
Type:
Application
Filed:
November 2, 2010
Publication date:
May 26, 2011
Applicants:
Regenerx Biopharmaceuticals, Inc., United States of America as Respresented by the Secretary of Health
Inventors:
Hynda K. Kleinman, Allan L. Goldstein, Katherine M. Malinda, Gabriel Sosne